Position in HROW
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$561,835
+$165,760 QoQ
Shares Held
13,229
+17.8% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#104
of 221 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Perigon Wealth Management, LLC holds $2,424,384 across 8 Drug Manufacturers - Specialty & Generic names. HROW ranks #1 (23.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HROW |
Harrow, Inc.
This page
|
13,229 | $561,835 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
15,717 | $544,908 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
3,524 | $390,952 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
594 | $321,847 | |
| 5 | VTRS |
Viatris Inc
|
16,003 | $254,127 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
16,628 | $240,939 | |
| 7 | HLN |
Haleon plc
|
10,544 | $98,375 | |
| 8 | ADCT |
ADC Therapeutics SA
|
10,656 | $11,401 |
All Filings in HROW
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $561,835 | 13,229 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $396,075 | 11,233 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $525,035 | 10,715 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $415,793 | 8,630 | Shares | Sole | 2025-10-17 | |
| No filing history on record for this holder in this stock. | ||||||